Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease: European Atherosclerosis Society/European Society of Vascular Medicine Joint Statement

Poor attainment of lipid targets in patients with symptomatic peripheral artery disease

doi: 10.1016/j.jacl.2018.02.013.

COMMENTED

Atrial FibrillationLipid-Lowering Drugs

Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

★ 3 Recommended and commented by Prof. Dr Isabella Sudano, Faculty Member

Atherosclerosis

Averna M, Banach M, Bruckert E, Drexel H, Farnier M, Gaita D, Magni P, März W, Masana L, Mello E Silva A, Reiner Z, Ros E, Vrablik M, Zambon A, Zamorano JL, Stock JK, Tokgözoğlu LS, Catapano AL

doi: 10.1016/j.atherosclerosis.2021.03.039

Lipid-Lowering Drugs

Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry

J Am Heart Assoc.

Xian Y, Navar AM, Li S, Li Z, Robinson J, Virani SS, Louie MJ, Koren A, Goldberg A, Roger VL, Wilson PWF, Peterson ED, Wang TY

doi: 10.1161/JAHA.119.013229.

Heart, Artery and Coronary DiseasesLipid-Lowering Drugs

Efficacy and Safety of Vorapaxar by Intensity of Background Lipid-Lowering Therapy in Patients With Peripheral Artery Disease: Insights From the TRA2P-TIMI 50 Trial

J Am Heart Assoc

Gilchrist IC Jr, Morrow DA, Creager MA, Olin JW, Scirica BM, Goodrich EL, Bonaca MP

doi: 10.1161/JAHA.121.021412

Heart, Artery and Coronary Diseases

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

Eur J Vasc Endovasc Surg.

Authors/Task Force Members, Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I, Document Reviewers, Widimsky P, Kolh P, Agewall S, Bueno H, Coca A, De Borst GJ, Delgado V, Dick F, Erol C, Ferrini M, Kakkos S, Katus HA, Knuuti J, Lindholt J, Mattle H, Pieniazek P, Piepoli MF, Scheinert D, Sievert H, Simpson I, Sulzenko J, Tamargo J, Tokgozoglu L, Torbicki A, Tsakountakis N, Tuñón J, de Ceniga MV, Windecker S, Zamorano JL

doi: 10.1016/j.ejvs.2017.07.018.

Heart, Artery and Coronary DiseasesLipid-Lowering DrugsThrombosis and StrokeTherapy and Intervention

Statins Have a Dose-Dependent Effect on Amputation and Survival in Peripheral Artery Disease Patients

Circulation

Arya S, Khakharia A, Binney ZO, DeMartino RR, Brewster LP, Goodney PP, Wilson PWF

doi: 10.1161/CIRCULATIONAHA.

Heart, Artery and Coronary Diseases

Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease

Circulation.

Gurbel PA, Fox KAA, Tantry US, Ten Cate H, Weitz JI

doi: 10.1161/CIRCULATIONAHA.118.033580.

Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesThrombosis and StrokeTherapy and Intervention

Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy

Eur Heart J

Aboyans V, Bauersachs R, Mazzolai L, Brodmann M, Palomares JFR, Debus S, Collet JP, Drexel H, Espinola-Klein C, Lewis BS, Roffi M, Sibbing D, Sillesen H, Stabile E, Schlager O, De Carlo M

doi: 10.1093/eurheartj/ehab390

Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesLipid-Lowering Drugs

Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular Disease

JAMA Cardiol.

Cannon CP, Khan I, Klimchak AC, Reynolds MR, Sanchez RJ, Sasiela WJ

doi: 10.1001/

Related content